Skip to content
Review Open access

Cardiac troponin I/T ratio and cardiovascular mortality risk in hypertensive adults without heart failure: a prospective NHANES cohort study

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

It is suggested that cTn I/T ratio may serve as a specific marker of CV risk stratification, but further studies are warranted to confirm its utility.

Abstract

Measurement of High-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity cardiac troponin I (hs-cTnI) as independent assays remain cornerstone of cardiology practice and are increasingly being recommended for early risk identification. Nevertheless, it remains unknown whether hs-cTn I/T ratio provides incremental prognostic value in hypertensive patients in the absence of heart failure (HF). This study aimed to investigate the prognostic association of hs-cTn I/T ratio and risk of cardiovascular and non-cardiovascular outcomes in patients with hypertension Data were obtained from the 1999–2004 National Health and Nutrition Examination Survey (NHANES) and linked to mortality records. Follow-up data was last updated until December 31, 2019. In adults aged ≥20 years with hypertension and no prior history of HF or established CVD (stroke, angina, myocardial infarction, coronary artery disease), we assessed the association between the cTnI/T ratio and risk of mortality outcomes using Cox proportional hazards model. The troponin I/T ratio was log₂-transformed prior to analysis. We analysed data on 31,126 participants, representing an estimated (weighted: 281.2M) non-institutionalized U.S. civilians. Of these, 4,234 met our inclusion criteria, majority 53.5% were females, mean age was 61 (46-72) years. Troponin ratios and associated demographics are summarised in Table 1 Results in Table 2 show that each log₂-unit increase in hs-cTn I/T ratio was associated with higher cardiovascular mortality after age and sex adjustment (HR 1.17, 95% CI 1.04–1.32; p=0.03). This remained significant after full multivariable adjustment (HR 1.19, 95% CI 1.06–1.34; p=0.005). No statistically significant associations were identified for all-cause mortality (HR 1.04, 95% CI 0.98–1.12; p=0.22), non-cardiovascular mortality (HR 0.99, 95% CI 0.90–1.08; p=0.74) or stroke (HR 1.21, 95% CI 0.96–1.54, p=0.11). Participants in the highest hs-cTn I/T ratio tertile had a greater risk of CV mortality relative to the lowest tertile (HR 1.36, 95% CI 1.04–1.72; p=0.03). In sensitivity analyses for CV mortality, the association of hs-cTn I/T ratio remained significant in males (HR 1.39, 95% CI 1.13–1.70; p=0.002). Use of the inverse hs-cTn T/I ratio yielded a reciprocal association (HR 0.84, 95% CI 0.75–0.95). Cardiac Troponin I/T ratio was associated with increased CV mortality, while showing no significant association with non-cardiovascular, stroke, and all-cause mortality. These findings suggest that cTn I/T ratio may serve as a specific marker of CV risk stratification, but further studies are warranted to confirm its utility.Table 1 troponin ratio and demographicsTable 2 showing troponin and mortality

Read PDF

Similar papers

Open access Oct 2026

High-sensitivity troponin-T concentrations and risk of heart failure in patients with acute pulmonary embolism

High-sensitivity cardiac troponins are the gold-standard biomarkers for diagnosing myocardial injury. We have previously shown that elevated high-sensitivity troponin-T (hsTnT) is associated with both short- and long-term mortality in patients with acute pulmonary embolism (PE). However, it is unknown whether hsT...

C. Byrne, M. Afzal, J. Frary et al. · 0 citations
Open access Oct 2026

Cardiac troponin elevations and risk of major adverse cardiovascular events in five non-cardiac diseases

Cardiac troponins (cTn) are biomarkers of myocardial injury and a cornerstone in the diagnosis of acute coronary syndrome (ACS); However, cTn elevations are frequently observed in non-cardiac diseases and have been associated with adverse outcomes. The prognostic implications and differences between high-sensitiv...

S. Knudsen, R. Hasselbalch, N. Strandkjaer et al. · 0 citations
Open access Oct 2026

Peak high-sensitivity troponin-T concentration and risk of heart failure in patients with suspected acute coronary syndrome

Acute coronary syndrome (ACS) is one of the most frequent causes of heart failure. In patients presenting with suspected ACS, it is currently unknown whether peak high-sensitivity troponin-T (hsTnT) is correlated with the short- and long-term risks of subsequent heart failure. To examine the short- and lon...

P. Ahle Erichsen, M. Afzal, J. Frary et al. · 0 citations
Nov 2026

Abstract 15431: The Association Between Peak High-Sensitivity Troponin-T Concentration and Risk of Heart Failure in Patients with Myocardial Infarction, Unstable Angina, and Suspected Myocardial Infarction

Background: In patients presenting with suspected acute coronary syndrome (ACS), peak high-sensitivity troponin-T (hsTnT) has been associated with an increased risk of heart failure; however, whether hsTnT is independently associated with subsequent heart failure regardless of the final diagnosis is currently unknow...

P. Ahle Erichsen, Majid Afzal, J. Frary et al. · 0 citations
Review Open access 2026

Diagnostic performance of AASI, NT-proBNP, and hs-cTnI for target-organ damage in older patients with hypertension: A systematic review

Background: Hypertension-mediated target organ damage (TOD) is a major determinant of cardiovascular and renal outcomes in older adults. Circulating biomarkers reflecting cardiac stress and myocardial injury, including N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin I (hs-cTn...

Han-Ning Wang, Hai-Wei Sun, Hao-Ran Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.